OncoSec Medical (DE:ONMA)
FRANKFURT:ONMA
Holding DE:ONMA?
Track your performance easily

OncoSec Medical (ONMA) Cash flow

1 Followers

OncoSec Medical Cash Flow

DE:ONMA's free cash flow for Q2 2023 was $―. For the 2023 fiscal year, DE:ONMA's free cash flow was decreased by $10.21M and operating cash flow was $-6.61M. See a summary of the company’s cash flow.
Cash Flow
TTM
Jul 22Jul 21Jul 20Jul 19Jul 18
Operating Cash Flow
$ -24.99M$ -32.14M$ -41.79M$ -33.15M$ -29.00M$ -23.22M
Investing Cash Flow
$ -11.46K$ -244.86K$ -799.60K$ 0.00$ 23.20M$ -23.29M
Financing Cash Flow
$ 3.54M$ -1.16M$ 68.21M$ 28.40M$ 27.20M$ 38.88M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 41.27M$ 12.30M$ 45.95M$ 20.35M$ 25.15M$ 3.80M
Income Tax Paid Supplemental Data
$ 2.97K$ 2.97K$ 4.99K$ 2.45K$ 1.70K$ 680.00
Interest Paid Supplemental Data
$ 26.01K$ 20.93K$ 10.30K$ 3.18K$ 3.25K$ 0.00
Issuance Of Capital Stock
$ 3.50M-$ 57.00M$ 30.00M$ 27.90M$ 32.28M
Issuance Of Debt
$ -670.41K$ -1.33M$ -619.11K$ 952.74K$ 0.00-
Repayment Of Debt
$ -865.34K$ -1.33M$ -619.11K$ -138.24K$ -81.58K$ 0.00
Free Cash Flow
$ -18.12M$ -32.38M$ -42.59M$ -33.15M$ -29.01M$ -23.29M
Domestic Sales
------
Foreign Sales
------
Currency in USD

OncoSec Medical Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis